<DOC>
	<DOCNO>NCT00450190</DOCNO>
	<brief_summary>The aim study evaluate E-Device performance handle use common practice , collect impression patient , nurse investigator graphic interface , instruction manual , E-Device training material .</brief_summary>
	<brief_title>Saizen® E-Device User Trial</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>1 . Patients naïve , experienced , Saizen® growth disorder register indication ( GHD , Turner 's Syndrome , Chronic Renal Failure , patient bear SGA accord local SmPC ) 2 . Written informed consent must obtain parent ( ) /legal guardian ( ) begin study . Children able understand trial personally sign date write informed consent 1 . Known hypersensitivity somatropin excipients 2 . Epiphyseal fusion 3 . Active neoplasia ( either newly diagnose recurrent ) 4 . History intracranial hypertension papilledema 5 . Diabetes mellitus history significant glucose intolerance define fast blood glucose &gt; 116 mg/dL 6 . Severe congenital malformation 7 . Severe psychomotor retardation 8 . Known hepatic disease define elevate liver enzymes total bilirubin ( x 2 N ) 9 . Current congestive heart failure , untreated hypertension , serious chronic oedema cause 10 . Chronic infectious disease 11 . Previous ongoing treatment sex steroid therapy estrogens testosterone 12 . Previous ongoing treatment therapy may directly influence growth , include GH , GHRF long duration corticosteroid therapy 13 . Proliferative preproliferative diabetic retinopathy 14 . Evidence progression recurrence underlie intracranial space occupy lesion 15 . Precocious puberty 16 . Severe associated pathology affect growth malnutrition , malabsorption bone dysplasia 17 . Concomitant corticoid treatment levothyroxine treatment substitutive treatment , topical inhale treatment 18 . Participation clinical study within 30 day precede study entry 19 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Growth disorders/drug therapy</keyword>
</DOC>